AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio
Go back to AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio| AbbVie (NYSE: ABBV) | Delayed: 284.80 -4.28 (1.48%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.08 | 52 Week High | $68.12 | |||
| Open | $287.63 | 52 Week Low | $50.71 | |||
| Day High | $289.00 | P/E | 61.78 | |||
| Day Low | $282.15 | EPS | $4.61 | |||
| Volume | 4,394,198 | |||||



